Synthesis and pharmacological activity N-aryloxyethyl derivatives of 9H-2,3-dihydroimidazo- and 10H-2,3,4,10-tetrahydropyrimido[1,2-a]benzimidazoles was written by Anisimova, V. A.;Spasov, A. A.;Stepanov, A. V.;Ar’kova, N. V.;Jakovlev, D. S.. And the article was included in Pharmaceutical Chemistry Journal in 2006.HPLC of Formula: 24134-26-7 This article mentions the following:
A series of N-aryloxyethyl derivatives of 9H-2,3-dihydroimidazo- and 10H-2,3,4,10-tetrahydropyrimido-[1,2-a]benzimidazoles, e.g. I·HCl, have been synthesized and tested for pharmacol. properties. It is established that most of the synthesized substances exhibit antiarrhythmic, antiaggregant and hemorheol. activity. In the experiment, the researchers used many compounds, for example, 2,3-Dihydro-1H-benzo[d]imidazo[1,2-a]imidazole (cas: 24134-26-7HPLC of Formula: 24134-26-7).
2,3-Dihydro-1H-benzo[d]imidazo[1,2-a]imidazole (cas: 24134-26-7) belongs to imidazole derivatives. Many natural products, especially alkaloids, contain the imidazole ring. These imidazoles share the 1,3-C3N2 ring but feature varied substituents. Imidazole also acts as a microtubule destabilizing agents and inhibits topoisomerase and Cytochrome P450 Family 26 Subfamily A Member 1 (CYP26A1) enzymes.HPLC of Formula: 24134-26-7
Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem